No Data
No Data
Zhejiang Cheng Yi Pharmaceutical (603811.SH) annual equity distribution in 2023: distribute 0.2 yuan per share, with June 7 as the record date.
Zhejiang Cheng Yi Pharmaceutical (603811.SH) released the implementation announcement of 2023 annual equity distribution, and the profit distribution this time is based on ...
Chengyi Pharmaceutical (603811.SH): Net profit of 32.685 million yuan in the first quarter, down 17.77% year on year
On April 25, Ge Longhui Pharmaceutical (603811.SH) released its report for the first quarter of 2024. During the reporting period, it achieved operating income of 153 million yuan, an increase of 3.54%; net profit attributable to shareholders of listed companies was 32.685 million yuan, a year-on-year decrease of 17.77%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 308.902 million yuan, a year-on-year decrease of 20.40%; and basic earnings per share were 0.1 yuan.
Express News | Sincerity Pharmaceutical: Lidocaine hydrochloride injection passed generic drug consistency evaluation
Sincerity Pharmaceutical (603811.SH): The controlling shareholders' concerted actions increased their total shareholding by 1.05%
On March 7, Gelonghui Pharmaceutical (603811.SH) announced that as of the disclosure date of this announcement, the controlling shareholders' concerted actions increased their holdings by a total of 3,424,722 shares, accounting for 1.05% of the company's total share capital.
Express News | Nearly 20 listed companies disclosed plans to repurchase or increase holdings after the market and announced that Zhifei Biotech plans to buy back 300 million yuan and use it for cancellation
Express News | Sincerity Pharmaceutical: The controlling shareholder plans to increase the company's shares by 15 million yuan to 30 million yuan
No Data